Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Biochemical and Biophysical Research Communications
|
September 15, 2009
Direct effects of osteoprotegerin on human bone cell metabolism
Alexander Grundt, Ingo Alexander Grafe, Ute Liegibel, et al.
The Journal of Biological Chemistry
|
December 14, 2016
Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells
Jakob Morgenstern, Thomas Fleming, Dagmar Schumacher, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
May 19, 2010
[Acceptance- and mindfulness-based group intervention in advanced type 2 diabetes patients: therapeutic concept and practical experiences]
Verena Faude-Lang, Mechthild Hartmann, Eva-Maria Schmidt, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
August 21, 2003
[Osteoporosis and cardiovascular disease--two sides of the same coin?]
Peter Nawroth, Rainer Pirzer, Berthold Fohr, et al.
Stroke
|
January 24, 2013
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban
Wei Zhou, Markus Zorn, Peter Nawroth, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 12, 2018
Pleiotropic Effect of Lipoprotein-Apheresis on the Soluble Form of Activated Leukocyte Cell Adhesion Molecule (sALCAM) in Familial Hypercholesterolaemia
Rüdiger von Bauer, Dimitrios Oikonomou, Alba Sulaj, et al.
European Journal of Endocrinology
|
November 14, 2008
Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism
Sonja-Kerstin Meyer, Markus Zorn, Karin Frank-Raue, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 9, 2019
Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis
Sergio Modafferi, Markus Ries, Vittorio Calabrese, et al.
BMC Endocrine Disorders
|
April 12, 2014
Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
Gudrun Leidig-Bruckner, Sonja Grobholz, Thomas Bruckner, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 19, 2002
[Do markers of bone metabolism reflect the presence of a high- or low-turnover state of bone metabolism?]
Beate Mehl, Günter Delling, Ingo Schlindwein, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Biochemical and Biophysical Research Communications
|
September 15, 2009
Direct effects of osteoprotegerin on human bone cell metabolism
Alexander Grundt, Ingo Alexander Grafe, Ute Liegibel, et al.
The Journal of Biological Chemistry
|
December 14, 2016
Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells
Jakob Morgenstern, Thomas Fleming, Dagmar Schumacher, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
May 19, 2010
[Acceptance- and mindfulness-based group intervention in advanced type 2 diabetes patients: therapeutic concept and practical experiences]
Verena Faude-Lang, Mechthild Hartmann, Eva-Maria Schmidt, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
August 21, 2003
[Osteoporosis and cardiovascular disease--two sides of the same coin?]
Peter Nawroth, Rainer Pirzer, Berthold Fohr, et al.
Stroke
|
January 24, 2013
Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban
Wei Zhou, Markus Zorn, Peter Nawroth, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 12, 2018
Pleiotropic Effect of Lipoprotein-Apheresis on the Soluble Form of Activated Leukocyte Cell Adhesion Molecule (sALCAM) in Familial Hypercholesterolaemia
Rüdiger von Bauer, Dimitrios Oikonomou, Alba Sulaj, et al.
European Journal of Endocrinology
|
November 14, 2008
Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism
Sonja-Kerstin Meyer, Markus Zorn, Karin Frank-Raue, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 9, 2019
Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis
Sergio Modafferi, Markus Ries, Vittorio Calabrese, et al.
BMC Endocrine Disorders
|
April 12, 2014
Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
Gudrun Leidig-Bruckner, Sonja Grobholz, Thomas Bruckner, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 19, 2002
[Do markers of bone metabolism reflect the presence of a high- or low-turnover state of bone metabolism?]
Beate Mehl, Günter Delling, Ingo Schlindwein, et al.
Page
of 11